PNC Financial Services Group
RVNC

PNC Financial Services Group’s Revance Therapeutics, Inc. RVNC Stock Holding History

PNC Financial Services Group’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-210
Closed -$1.03K – 4938
2024
Q1 		$1.03K Sell
210
-33
-14% -$195 ﹤0.01% 4361
2023
Q4 		$2.13K Sell
243
-65
-21% -$533 ﹤0.01% 4178
2023
Q3 		$3.53K Sell
308
-121
-28% -$2.33K ﹤0.01% 4086
2023
Q2 		$10.9K Sell
429
-221
-34% -$6.88K ﹤0.01% 3842
2023
Q1 		$20.9K Hold
650
– – ﹤0.01% 3473
2022
Q4 		$12K Buy
650
+178
+38% +$4.07K ﹤0.01% 3706
2022
Q3 		$13K Hold
472
– – ﹤0.01% 3651
2022
Q2 		$6K Hold
472
– – ﹤0.01% 3965
2022
Q1 		$10K Sell
472
-3,596
-88% -$54.5K ﹤0.01% 3837
2021
Q4 		$68K Buy
4,068
+3,583
+739% +$59.7K ﹤0.01% 2937
2021
Q3 		$14K Hold
485
– – ﹤0.01% 3651
2021
Q2 		$14K Hold
485
– – ﹤0.01% 3608
2021
Q1 		$14K Buy
485
+320
+194% +$8.85K ﹤0.01% 3553
2020
Q4 		$5K Hold
165
– – ﹤0.01% 3727
2020
Q3 		$5K Hold
165
– – ﹤0.01% 3686
2020
Q2 		$5K Buy
165
+33
+25% +$651 ﹤0.01% 3654
2020
Q1 		$1K Hold
132
– – ﹤0.01% 3839
2019
Q4 		$1K Buy
132
+84
+175% +$1.3K ﹤0.01% 3912
2019
Q3 		$0 Hold
48
– – ﹤0.01% 4130
2019
Q2 		$0 Hold
48
– – ﹤0.01% 4154
2019
Q1 		$0 Hold
48
– – ﹤0.01% 4151
2018
Q4 		$0 Hold
48
– – ﹤0.01% 4204
2018
Q3 		$2K Hold
48
– – ﹤0.01% 3978
2018
Q2 		$2K Hold
48
– – ﹤0.01% 4003
2018
Q1 		$2K Hold
48
– – ﹤0.01% 4066
2017
Q4 		$2K Buy
+48
New +$1.38K ﹤0.01% 4028

Other funds holding RVNC

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PNC Financial Services Group's RVNC Position: Q2 2024 in Review

PNC Financial Services Group sold out of Revance Therapeutics, Inc. (RVNC) in Q2 2024, closing a stake of 210 shares — an estimated $1.03K sold.

PNC Financial Services Group first reported a position in RVNC in Q4 2017 and held it in 26 quarters. The position peaked at $68K in Q4 2021. 173 funds tracked by Wall St. Rank hold RVNC as of Q2 2024.

  • PNC Financial Services Group reported no remaining Revance Therapeutics, Inc. position as of Q2 2024 after selling out during the quarter.
  • PNC Financial Services Group sold 210 Revance Therapeutics, Inc. shares in Q2 2024, an estimated $1.03K.
  • PNC Financial Services Group first reported a position in Revance Therapeutics, Inc. in Q4 2017 and held it in 26 quarters.
  • PNC Financial Services Group's Revance Therapeutics, Inc. position peaked at $68K in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q2 2024.

Based on PNC Financial Services Group's 13F filing for Q2 2024, filed 9 Aug 2024.